# A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

> **NCT00465803** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 81 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost 0.004%/timolol 0.5% ophthalmic solution
- **DRUG:** Travoprost ophthalmic solution, 0.004%
- **DRUG:** Timolol maleate ophthalmic solution, 0.5%

## Key facts

- **NCT ID:** NCT00465803
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-01
- **Final completion:** —
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2014-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465803, "A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00465803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*